Recombinant Human Anti-gp40 x Human Anti-TFRC Tandem scFv-ABR immunotoxin (Bispecific Immunotoxin) (BSFV-ABR030)

Recombinant Anti-gp40 x Anti-TFRC Tandem scFv-ABR immunotoxin (Bispecific Immunotoxin) is designed to be expressed as the abrin-a A chain (ABRa-A) fused to a tandem scFv recognizing gp40 and TFRC. It contains a His-tag at the C/N terminus for affinity purification. This bispecific immunotoxin can deliver ABRa-A to antigen-specific cells. Then ABR is a type II ribosome inactivating protein (RIP) and can kill the target cells. The bispecific immunotoxin is designed for the research of Colon cancer; Ovarian cancer therapy.

Datasheet INQUIRY

Specifications

Targets

gp40 & TFRC

Type

Bispecific Immunotoxin

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Colon cancer; Ovarian cancer

Targets

Target 1

gp40

Alternative Names

gp40; glycoprotein 40; adenocarcinoma-associated antigen

Target 2

TFRC

Gene ID

7037

UniProt ID

P02786

Alternative Names

TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-gp40 x Human Anti-TFRC Tandem scFv-ABR immunotoxin (Bispecific Immunotoxin) (BSFV-ABR030). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-gp40 x Human Anti-TFRC Tandem scFv-ABR immunotoxin (Bispecific Immunotoxin) (CAT#: BSFV-ABR030)

Specifications

Targets

Customer Reviews and Q&As